Annexin Pharmaceuticals AB
ANNX | FN
Overview
Corporate Details
- ISIN(s):
- SE0009664154
- LEI:
- 5493000JP703HGPJEX27
- Country:
- Sweden
- Address:
- KAMMAKARGATAN 48, 111 60 Stockholm
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Annexin Pharmaceuticals AB is a Swedish biotech company focused on therapies for cardiovascular and inflammatory diseases. Its pipeline is based on Annexin A5 protein.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS | |
|
Ascelia Pharma | Sweden | ACE |